当前位置:首页>产品中心>单抗/多抗>Anti-Human LILRB2/CD85d/ILT4 Reference Antibody|抗人LILRB2/CD85d/ILT4参考抗体(靶标:人白细胞免疫球蛋白样受体B2(ILT4))

Anti-Human LILRB2/CD85d/ILT4 Reference Antibody|抗人LILRB2/CD85d/ILT4参考抗体(靶标:人白细胞免疫球蛋白样受体B2(ILT4))

  • 货号:RB9THV255056
  • 价格:面议
  • 点击:364

产品介绍

产品参数

形态Liquid
宿主种属Human
克隆性Monoclonal
抗体亚型IgG4-kappa
纯度>95% purity as determined by SDS-PAGE.
纯化方式Protein A/G purified from cell culture supernatant.
浓度1mg/ml
内毒素水平Please contact the lab for this information.
应用ELISA, Bioactivity: FACS, Functional assay, Research in vivo
种属反应性Human
靶标CD85 antigen-like family member D, Monocyte/macrophage immunoglobulin-like receptor 10, MIR-10, ILT4, LIR-2, ILT-4, Immunoglobulin-like transcript 4, MIR10, CD85d, Leukocyte immunoglobulin-like recept
储存缓冲液0.01M PBS, pH 7.4.
稳定性和储存Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
表达系统Mammalian Cells
登录号Q8N423
背景信息Polzastobart (JTX-8064) is a humanized IgG4 monoclonal antagonist antibody that selectively binds LILRB2 and prevents it from binding its ligands, classical and non-classical MHC I molecules. Polzastobart enhances pro-inflammatory cytokine production in macrophages by blocking the ability of LILRB2 to bind HLA-A/B and/or HLA-G, a marker of immunotolerance on cancer cells. Polzastobart is a macrophage immune checkpoint inhibitor.
别名2640981-19-5
备注For research use only. Not suitable for clinical or therapeutic use.
【仅供科学研究使用】

相关产品:
总计 33037 个记录,共 1652 页,当前第 1 页 | 第一页 上一页 下一页 最末页
在线客服
  • 销售热线:
  • 15898894496(同微信)
  • 我要留言
  • 周一至周五每天9:00-17:00